Tilray (TLRY)

Tilray Stock Analysis & Ratings



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $3.00 and its highest was $15.21 in the past 12 months.
    What is Tilray’s market cap?
    Currently, no data Available
    What is Tilray’s price target?
    The average price target for Tilray is $4.68. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $9.00 ,the lowest forecast is $3.00. The average price target represents 8.96% Increase from the current price of $4.295.
      What do analysts say about Tilray?
      Tilray’s analyst rating consensus is a ‘Hold. This is based on the ratings of 9 Wall Streets Analysts.
        When is Tilray’s upcoming earnings report date?
        Tilray’s upcoming earnings report date is Oct 06, 2022 which is in 58 days.
          How were Tilray’s earnings last quarter?
          Tilray released its earnings results on Jul 28, 2022. The company reported -$0.9 earnings per share for the quarter, missing the consensus estimate of -$0.08 by -$0.82.
            Is Tilray overvalued?
            According to Wall Street analysts Tilray’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Tilray pay dividends?
              Tilray does not currently pay dividends.
              What is Tilray’s EPS estimate?
              Tilray’s EPS estimate is -$0.07.
                How many shares outstanding does Tilray have?
                Tilray has 536,390,750 shares outstanding.
                  What happened to Tilray’s price movement after its last earnings report?
                  Tilray reported an EPS of -$0.9 in its last earnings report, missing expectations of -$0.08. Following the earnings report the stock price went up 11.963%.
                    Which hedge fund is a major shareholder of Tilray?
                    Among the largest hedge funds holding Tilray’s share is Bridgewater Associates, LP. It holds Tilray’s shares valued at N/A.


                      Tilray Stock Analysis

                      Smart Score
                      Price Target
                      ▲(8.96% Upside)
                      The Tilray stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

                      Similar Stocks
                      Price & Change
                      Johnson & Johnson
                      Eli Lilly & Co
                      Merck & Company
                      Bristol Myers

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis